Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hefei CAS Ion Medical and Technical Devices (HMC) is a high-tech enterprise focused on the development and commercialization of advanced radiotherapy equipment, specifically superconducting proton therapy systems. Established through a collaboration involving the Chinese Academy of Sciences (CAS) and the Hefei municipal government, the company aims to localize the production of high-end medical equipment to treat cancer. Their flagship product is a compact superconducting cyclotron-based proton therapy system designed to provide precise radiation treatment while minimizing damage to healthy tissue. HMC operates as a key player in China's medical physics and nuclear medicine sector, integrating research, manufacturing, and clinical application.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hefei Medical.